| Literature DB >> 26108218 |
Yasutaka Kakui1, Tomonari Sunaga2, Kunio Arai3, James Dodgson4, Liang Ji3, Attila Csikász-Nagy5, Rafael Carazo-Salas4, Masamitsu Sato6.
Abstract
Integration of an external gene into a fission yeast chromosome is useful to investigate the effect of the gene product. An easy way to knock-in a gene construct is use of an integration plasmid, which can be targeted and inserted to a chromosome through homologous recombination. Despite the advantage of integration, construction of integration plasmids is energy- and time-consuming, because there is no systematic library of integration plasmids with various promoters, fluorescent protein tags, terminators and selection markers; therefore, researchers are often forced to make appropriate ones through multiple rounds of cloning procedures. Here, we establish materials and methods to easily construct integration plasmids. We introduce a convenient cloning system based on Golden Gate DNA shuffling, which enables the connection of multiple DNA fragments at once: any kind of promoters and terminators, the gene of interest, in combination with any fluorescent protein tag genes and any selection markers. Each of those DNA fragments, called a 'module', can be tandemly ligated in the order we desire in a single reaction, which yields a circular plasmid in a one-step manner. The resulting plasmids can be integrated through standard methods for transformation. Thus, these materials and methods help easy construction of knock-in strains, and this will further increase the value of fission yeast as a model organism.Entities:
Keywords: chromosomal integration; cloning; fission yeast; fluorescent protein; plasmid
Mesh:
Substances:
Year: 2015 PMID: 26108218 PMCID: PMC4632507 DOI: 10.1098/rsob.150054
Source DB: PubMed Journal: Open Biol ISSN: 2046-2441 Impact factor: 6.411
Figure 1.The Golden Gate method to create integration plasmids. (a) A schematic of an integration plasmid. (left) An example of an integration plasmid to express a GOI in fusion with a fluorescent protein (FP) tag under a promoter. A target module comprises tar.F and tar.R regions separated by an FseI restriction site. (right) An integration plasmid can be linearized with FseI, and tar.F and tar.R sequences are targeted to the homologous sequences on the S. pombe chromosome, to induce homologous recombination. (b) A schematic for the Golden Gate reaction. (left) Examples of module elements. Modules are given either as plasmids (1, 3–6) or as PCR products (2). Modules for a promoter module (1), GOI (2), an FPtag (3), a selection marker (4), a target region (5), the vector backbone (6). a–f: cohesive ends to connect modules 1–6 in this order. (right) A reaction protocol for the Golden Gate reaction by the mixture of 1–6 and the resulting circular integration plasmid (7). Each module plasmid (1, 3–6) contains the kanamycin resistance gene (KanR), whereas the final product (integration plasmid, 7) is ampicillin resistant. (c) Unique property of BsaI. (left) EcoRI, a standard restriction enzyme, cleaves its recognition site, therefore digestion and religation can be repeated. (right) By contrast, BsaI has separate sites for recognition (GGTCTC) and digestion (NNNN; any four bases).
Figure 2.Choice of module plasmids for expression of a C-terminal tagged GOI. (a) Detailed illustration of an integration plasmid for expression of the GOI–GFP fusion (C-terminal GFP tag). Modules I–V are connected in the pFA6a-based vector (module VI) in that order. In this example, the adh1 promoter (selected from group I modules) drives expression of the fusion gene of the GOI (GOI (bc), II) with GFP (FPtag-C (cd), III). Tadh serves as a terminator. kan (PTEF, promoter; TTEF, terminator) is a selection marker used after S. pombe transformation (module IV). Target module (V) is the sequence that is targeted to a homologous sequence in S. pombe chromosomes. Useful restriction sites are also indicated. Digestion with NotI separates the vector and other modules. JB19F and JB20R correspond to sequences commonly used in PCR-based gene targeting [12]. a–f in module names indicate the names of BsaI cohesive ends used therein (c). AmpR, the ampicillin resistance gene. (b,c) List of module plasmids created in this study. (b) Modules are categorized as groups I–VI in boxes. Choose one module from each group to mix. II. The GOI (bc) is made through PCR to add cohesive ends (‘b’ and ‘c’). Group IIIa, instead of II and III, can be used to make control strains. Modules for the adh terminator and a selection marker gene can be supplied together (group IV). Alternatively, each module can be chosen separately: a terminator (group IVa) and a selection marker (group IVb). (c) Sequences of cohesive ends named a–g. Note that the module vector pBMod contains a BsaI site with the cohesive end GTTA.
Module plasmids created in this study. Systematic numbers (denoted with # throughout the manuscript) and plasmid names are listed with module contents. Each module was PCR-amplified from the indicated origin template to add particular cohesive ends, the names of which are listed in ‘names of cohesive ends’ (a–g shown in figure 2c and table 2). The amplified module fragment was cloned into pCR-Blunt II-TOPO. The vector name pBMod indicates pCR-Blunt II-TOPO-based module plasmid. An Excel version of this table is available in the electronic supplementary material.
| module plasmids | modules (contents) | name of cohesive ends (left, right) | origin | literature | notes | ||
|---|---|---|---|---|---|---|---|
| number | name | ||||||
| I. Promoter (ab) | |||||||
| figures | 1 | pBMod-Padh1(ab) | Padh1 | a, b | Russell & Hall [ | ||
| 2 | pBMod-Padh41(ab) | Padh41 | a, b | Padh1, mutagenesis | Yamagishi | ||
| 3 | pBMod-Padh81(ab) | Padh81 | a, b | Padh1, mutagenesis | Yokobayashi & Watanabe [ | ||
| 4 | pBMod-Pnmt1(ab) | Pnmt1 | a, b | Maundrell [ | |||
| 5 | pBMod-Pnmt41(ab) | Pnmt41 | a, b | Pnmt1, mutagenesis | Basi | ||
| 6 | pBMod-Pnmt81(ab) | Pnmt81 | a, b | Pnmt1, mutagenesis | Basi | ||
| 7 | pBMod-Purg1(ab) | Purg1 | a, b | pFA6a-kanMX6-Purg1 | Watt | ||
| III. FPtag-C (cd) | |||||||
| 8 | pBMod-L-GFP(cd) | L-GFPa | c, d | pFA6a-GFP(S65T)-kanMX | Bähler | BsaI removed | |
| (C tag) | 9 | pBMod-L-mCherry(cd) | L-mCherrya | c, d | pFA6a-mCherry-hphMX | Sato | |
| 10 | pBMod-L-ECFP(cd) | L-ECFPa | c, d | pFA6a-ECFP-natMX | Sato | ||
| IIIa. FPcontrol-C (bd) | |||||||
| 11 | pBMod-cont-L-GFP(bd) | control L-GFPa | b, d | pFA6a-GFP(S65T)-kanMX | Bähler | BsaI removed | |
| 12 | pBMod-cont-L-mCherry(bd) | control L-mCherrya | b, d | pFA6a-mCherry-hphMX | Sato | ||
| 13 | pBMod-cont-L-ECFP(bd) | control L-ECFPa | b, d | pFA6a-ECFP-natMX | Sato | ||
| VII. FPtag-N (bc) | |||||||
| (N tag) | 14 | pBMod-GFP-L(bc) | GFP-La | b, c | pFA6a-GFP(S65T)-kanMX | Bähler | BsaI removed |
| 15 | pBMod-mCherry-L(bc) | mCherry-La | b, c | pFA6a-mCherry-hphMX | Sato | ||
| 16 | pBMod-ECFP-L(bc) | ECFP-La | b, c | pFA6a-ECFP-natMX | Sato | ||
| VIIa. FPcontrol-N (bd) | |||||||
| 17 | pBMod-cont-GFP-L(bd) | control GFP-La | b, d | pFA6a-GFP(S65T)-kanMX | Bähler | BsaI removed | |
| 18 | pBMod-cont-mCherry-L(bd) | control mCherry-La | b, d | pFA6a-mCherry-hphMX | Sato | ||
| 19 | pBMod-cont-ECFP-L(bd) | control ECFP-La | b, d | pFA6a-ECFP-natMX | Sato | ||
| figures | IV. Terminator + Marker (de) | ||||||
| 20 | pBMod-Tadh-kan(de) | Tadh- | d, e | pFA6a-GFP(S65 T)-kanMX | Bähler | ||
| 21 | pBMod-Tadh-hph(de) | Tadh- | d, e | pFA6a-mCherry-hphMX | Sato | ||
| 22 | pBMod-Tadh-nat(de) | Tadh- | d, e | pFA6a-ECFP-natMX | Sato | ||
| 23 | pBMod-Tadh-bsd(de) | Tadh- | d, e | pCR2.1-bsd | Kimura | ||
| IVa. Terminator (dg) | |||||||
| 24 | pBMod-Tadh(dg) | Tadh | d, g | pFA6a-GFP(S65 T)-kanMX | Bähler | ||
| IVb. Marker (ge) | |||||||
| 25 | pBMod-kan(ge) | g, e | pFA6a-GFP(S65 T)-kanMX | Bähler | |||
| 26 | pBMod-hph(ge) | g, e | pFA6a-mCherry-hphMX | Sato | |||
| 27 | pBMod-nat(ge) | g, e | pFA6a-ECFP-natMX | Sato | |||
| 28 | pBMod-bsd(ge) | g, e | pCR2.1-bsd | Kimura | |||
| 29 | pBMod-ura4 + (ge) | g, e | pREP2 | Maundrell [ | |||
| 30 | pBMod-LEU2(ge) | g, e | pREP1 | Maundrell [ | |||
| figures | V. Target (ef) | ||||||
| 31 | pBMod-co2(ef) | co2 | e, f | this study | |||
| 32 | pBMod-Z2(ef) | Z2 | e, f | Akera | |||
| 33 | pBMod-lys1(ef) | e, f | |||||
| 34 | pBMod-arg1(ef) | e, f | |||||
| figures | VI. Vector (fa) | ||||||
| 35 | pBMod-AmpVec(fa) | f, a | pFA6a | Wach | |||
aL, linker.
Figure 3.Choice of module plasmids for expression of FP-GOI. (a) Detailed construct of an integration plasmid for expression of a GFP–GOI (N-terminal GFP tag). Modules chosen from groups I, VII, VIII, IV, V and VI are connected in this order. The adh1 promoter (Padh1, group I) drives expression of the fusion gene GFP–GOI (groups VII and VIII). The plasmid digested with FseI can be targeted to the co2 locus of chromosome I by the co2 module (IV). Representative restriction sites are also shown. (b) List of module plasmids used for Golden Gate reaction to construct integration plasmids to express a GOI with an N-terminal FP tag (also see table 1). The GOI (cd) is a PCR product containing cohesive ends (‘c’ and ‘d’). To make control plasmids expressing fluorescent proteins without a GOI, a module from group VIIa can be used instead of VII and VIII. See figure 2b for other module groups. a–g: cohesive ends, sequences of which are shown in figure 2c.
Guideline for designing oligonucleotide primers with cohesive ends. When a new module is to be made, design a pair of oligonucleotide primers, the sequences of which are shown in the table. ‘Specific 20b’ corresponds to the 20-base sequence of the template gene to be amplified. The length (20 bases) can be varied depending on the situation. Note that the BsaI recognition site is ‘GGTCTC’. By setting up the rule above to choose cohesive ends, we can modulate the order in which modules are connected. FWD, forward primer; REV, reverse primer; rev. comp., reverse complement. An Excel version of this table is available in the electronic supplementary material.
| cohesive ends | ||||||
|---|---|---|---|---|---|---|
| modules and oligo direction | name | sequences (rev. comp.) | sequences of oligonucleotide primers (bold indicates a cohesive end) | notes | plasmids using this end (see | |
| figures | I. Promoter (ab) | |||||
| FWD | a | 5′-tttGGTCTCa | # 1–7 | |||
| REV | b | 5′-tttGGTCTCa | the cohesive end includes the initiation codon | # 1–7 | ||
| II. GOI (bc) | ||||||
| (C tag) | FWD | b | 5′-tttGGTCTCa | the cohesive end includes the initiation codon | ||
| REV | c | 5′-tttGGTCTCa | ||||
| III. FPtag-C (cd) | ||||||
| FWD | c | 5′-tttGGTCTCa | # 8–10 | |||
| REV | d | 5′-tttGGTCTCa | # 8–10 | |||
| IIIa. FPcontrol-C (bd) | ||||||
| FWD | b | 5′-tttGGTCTCa | the cohesive end includes the initiation codon | # 11–13 | ||
| REV | d | same as II-REV(d) | # 11–13 | |||
| IIIa. GOI with small tag-C (bd) | ||||||
| FWD | b | 5′-tttGGTCTCa | the cohesive end includes the initiation codon | |||
| REV | d | 5′-tttGGTCTCa | Tag sequence (e.g. HA, FLAG) is inserted before termination codon | |||
| figures | IIIa. GOI (bd) (without tag) | |||||
| FWD | b | 5′-tttGGTCTCa | the cohesive end includes the initiation codon | |||
| REV | d | 5′-tttGGTCTCa | ||||
| VII. FPtag-N (bc) | ||||||
| (N tag) | FWD | b | 5′-tttGGTCTCa | the cohesive end includes the initiation codon | # 14–16 | |
| REV | c | 5′-tttGGTCTCa | # 14–16 | |||
| VIIa. FPcontrol-N (bd) | ||||||
| FWD | b | same as IV-FWD(b) | the cohesive end includes the initiation codon | # 17–19 | ||
| REV | d | 5′-tttGGTCTCa | # 17–19 | |||
| VIIa. GOI with small tag-N (bd) | ||||||
| FWD | b | 5′-tttGGTCTCa | Tag sequence is inserted between initiation codon and GOI | |||
| REV | d | 5′-tttGGTCTCa | ||||
| VIII. GOI (cd) | ||||||
| FWD | c | 5′-tttGGTCTCa | start GOI from the second codon in frame after | |||
| REV | d | 5′-tttGGTCTCa | ||||
| figures | IV. Terminator + Marker (de) | |||||
| FWD | d | 5′-tttGGTCTCa | # 20–23 | |||
| REV | e | 5′-tttGGTCTCa | # 20–23 | |||
| IVa. Terminator (dg) | ||||||
| FWD | d | 5′-tttGGTCTCa | # 24 | |||
| REV | g | 5′-tttGGTCTCa | # 24 | |||
| IVb. Marker (ge) | ||||||
| FWD | g | 5′-tttGGTCTCa | # 25–30 | |||
| REV | e | 5′-tttGGTCTCa | # 25–30 | |||
| figures | V. Target (ef) | |||||
| FWD | e | 5′-tttGGTCTCa | # 31–34 | |||
| REV | f | 5′-tttGGTCTCa | # 31–34 | |||
| figures | VI. Vector (fa) | |||||
| FWD | f | 5′-tttGGTCTCa | includes the | # 35 | ||
| REV | a | 5′-tttGGTCTCa | includes the | # 35 | ||
aThe codon frame is indicated with a space.
Figure 4.Construct of target modules. The lys1 target module is shown as an example. (a,b) A schematic illustrating how target modules were made. (a) An approximately 1 kb region of the lys1+ gene was chosen as a target site. The first half of the region was termed lys1F, and the second half lys1R. White arrow and arrowheads indicate the direction of the coding sequence of lys1+. (b) In the lys1 target module plasmid (#33, group V), the lys1R and lys1F fragments have been connected in this order with an FseI site between them. e,f: cohesive ends shown in figure 2c. (c,d) The principle of how target module sequences work. (c) A schematic of an integration plasmid made with the module plasmid through a Golden Gate reaction. (d) Linearization of the plasmid with FseI, followed by integration of the fragment into the lys1+ gene on S. pombe chromosome I through homologous recombination. The lys1 gene of the resultant strain is disrupted (top).
Figure 5.An application of the C-terminal tagging system. We constructed strains to visualize actin organization as a proof of principle. (a) Module plasmids used for Golden Gate reaction to make integration plasmids to express the actin-binding protein lifeact with GFP or mCherry. Pnmt1 (#4) or Pnmt41 (#5) module plasmids were chosen from the promoter module group I (1). The GOI module here (2) is the DNA fragment comprising the in-frame fusion gene of lifeact with GFP or mCherry. The fusion genes were made through PCR. Modules from 1 to 5 were mixed to perform a Golden Gate reaction. Modules are connected in the order shown here. (b) Standard fluorescence microscopy to confirm expression of lifeact-GFP and lifeact-mCherry. (left) Integration plasmids created through the Golden Gate method and used for transformation after linearization. 〈1〉, 〈2〉: plasmids for expression of lifeact-GFP under the nmt1 〈1〉 or nmt41 〈2〉 promoter. 〈3〉: a plasmid for expression of lifeact-mCherry under the nmt1 promoter. All constructs were inserted at the co2 site of chromosome I. (right) Observation of lifeact-GFP and lifeact-mCherry together with microtubule markers mCherry-Atb2 and GFP-Atb2, respectively, in the strains created with the integration plasmids. Images are maximum intensity projections of deconvolved stacks. (c) Results of colony PCR to examine proper integration of the linearized plasmid 〈1〉. (d) Structural illumination microscopy to confirm cytoplasmic actin cables (arrows) as well as patches visualized with Pnmt1-driven lifeact-GFP (the strain 〈1〉). Scale bars, 5 µm. The final image is a maximum-intensity projection of a 1 μm deep stack. (e) Head-on imaging of a cell expressing Pnmt1-driven lifeact-GFP. Images were taken every 0.125 µm along the z-axis. Scale bar, 2 µm.
S. pombe strains used in this study. leu1, leu1-32; ura4, ura4-D18.
| strain | genotype | origin | integration plasmid used | figure |
|---|---|---|---|---|
| MJ1100 | h90 Z2-GFP-atb2-kan leu1 ura4 ade6-M216 | this study | — | |
| MJ1105 | h90 Z2-mCherry-atb2-hph leu1 ura4 ade6-M216 | this study | — | |
| TOM0165 | h90 Z2-mCherry-atb2-hph co2::Pnmt1-lifeact-GFP-Tadh-kan leu1 ura4 ade6-M216 | this study | pFA-Pnmt1-lifeact-GFP-Tadh-kan-CO2 #1a | |
| TOM0167 | h90 Z2-mCherry-atb2-hph co2::Pnmt1-lifeact-GFP-Tadh-kan leu1 ura4 ade6-M216 | this study | pFA-Pnmt1-lifeact-GFP-Tadh-kan-CO2 #2a | |
| TOM0177 | h90 Z2-mCherry-atb2-hph co2::Pnmt41-lifeact-GFP-Tadh-kan leu1 ura4 ade6-M216 | this study | pFA-Pnmt41-lifeact-GFP-Tadh-kan-CO2 | |
| TOM0184 | h90 Z2-GFP-atb2-kan co2::Pnmt1-lifeact-mCherry-Tadh-hph leu1 ura4 ade6-M216 | this study | pFA-Pnmt1-lifeact-mCherry-Tadh-hph-CO2 |
aPlasmids #1 and #2 are two independent clones obtained from a single Golden Gate reaction.